Abstract
CD4+ T cells are critical for adaptive immunity, differentiating into distinct effector and regulatory subsets. Although the transcriptional programs underlying their differentiation are known, recent research has highlighted the importance of mRNA translation in determining protein abundance. We previously conducted genome-wide analysis of translation in CD4+ T cells revealing distinct translational signatures distinguishing these subsets, identifying eIF4E as a central differentially translated transcript. As eIF4E is vital for eukaryotic translation, we examined how altered eIF4E activity affected T cell function using mice lacking eIF4E-binding proteins (BP-/-). BP-/- effector T cells showed elevated Th1 responses ex vivo and upon viral challenge with enhanced Th1 differentiation observed in vitro. This was accompanied by increased TCR activation and elevated glycolytic activity. This study highlights how regulating T cell-intrinsic eIF4E activity can influence T cell activation and differentiation, suggesting the eIF4EBP-eIF4E axis as a potential therapeutic target for controlling aberrant T cell responses.
Original language | English (US) |
---|---|
Article number | 106683 |
Journal | iScience |
Volume | 26 |
Issue number | 5 |
DOIs | |
State | Published - May 19 2023 |
Bibliographical note
Funding Information:This work was funded by a Canadian Institutes of Health Research (CIHR) operating grant (PJT-148821) awarded to C.A.P. We thank the RI-MUHC Immunophenotyping Platform for their excellent cell sorting service. We also thank the RI-MUHC Proteomics Platform for their help in the design and execution of the proteomic analyses. Conceptualization: R.I. and C.A.P.; Investigation: R.I. T.A. and F.A.; Formal Analysis: R.I. and C.A.P.; Methodology: R.I. T.A. and F.A.; Writing – Original Draft: R.I. and C.A.P.; Writing – Review & Editing: R.I. T.A. F.A. and C.A.P.; Funding Acquisition: C.A.P.; Resources: J.A.S. C.W. and C.A.P. The authors declare no competing interests.
Funding Information:
This work was funded by a Canadian Institutes of Health Research (CIHR) operating grant ( PJT-148821 ) awarded to C.A.P. We thank the RI-MUHC Immunophenotyping Platform for their excellent cell sorting service. We also thank the RI-MUHC Proteomics Platform for their help in the design and execution of the proteomic analyses.
Publisher Copyright:
© 2023
Keywords
- Biological sciences
- Immunology
- Molecular biology
- Proteomics
PubMed: MeSH publication types
- Journal Article